
EXTON, PA, June 25, 2025 – In the current scenario, hospitals are under increasing pressure to deliver patient-specific medical devices proficiently. In response, Ricoh USA has launched Ricoh 3D for Healthcare, a division focused on expanding access to FDA-cleared, 3D-printed medical devices. The goal is to help healthcare providers integrate precision manufacturing into clinical workflows while addressing scalability, compliance, and turnaround challenges. The company is also exploring how this model could reshape personalized healthcare delivery.
The market for 3D printed medical devices is projected to grow from $5.59 billion in 2025 to $24.69 billion by 2034. Ricoh will help respond to growth in the field, address the needs of clinical clients, and support work on regulatory guidance and standardization.
“The establishment of Ricoh 3D for Healthcare is the natural next step in the evolution of a business Ricoh has been incubating for five years,” said Gary Turner, vice president and general manager, Ricoh 3D for Healthcare. “As we rapidly scale and enter an accelerated growth phase of the business, it is essential that we have the right structure in place to realize and maximize the potential that Ricoh has envisioned for this business from the beginning.”
Ricoh 3D for Healthcare offers patient-specific solutions, including FDA (Food and Drug Administration)-cleared anatomic models and on-site manufacturing studios that enable hospitals to produce medical devices within their facilities. Ricoh 3D for Healthcare collaborates with Kallisio (oral stents for head and neck cancer) and Insight Surgery (oncology and osteotomy surgical guides), to manufacture and distribute patient-specific devices nationwide. Ricoh 3D for Healthcare takes a central role that supports personalized care across a network of partners.
Precision healthcare is receiving attention. The FDA develops regulatory frameworks for 3D1,2 as well as review and clear personalized 3D printed implants3 and surgical tools. Momentum is also built for reimbursement, with CPT (Current Procedural Terminology) and HCPCS (Healthcare Common Procedure Coding System) codes4 to cover 3D visualization, planning and printing.
“Ricoh 3D for Healthcare is a pioneer in this industry. An example is our point-of-care 3D medical device manufacturing facility at Atrium Health, which gives clinicians immediate access to 3D printed anatomic models and support,” said Turner. “Our ability to operate independently will allow us to accelerate similar types of innovation, facilitating opportunities to partner, innovate and collaborate.”
1 Technical Considerations for Additive Manufactured Medical Devices – Guidance for Industry and Food and Drug Administration Staff
2 3D Printing Medical Devices at the Point of Care: Discussion Paper | FDA
3 https://www.3dnatives.com/en/3d-printed-spinal-devices-approved-by-fda-021020246/#!
4 https://www.aapc.com/codes/hcpcs-codes/C8001
Source: Ricoh
About Ricoh

Ricoh Company, Ltd., founded in 1936, is a Japanese multinational headquartered in Tokyo, with a focus on imaging, printing, and digital services. The company provides products, including office printers, multifunction devices, production printing systems, and digital cameras, along with IT and workflow automation services. Ricoh serves industries such as healthcare, education, finance, and manufacturing, supporting organizations in managing documents, streamlining operations, and enabling digital transformation. The company operates in 200 countries and regions, drawing on technical expertise and operational capabilities developed over more than eight decades. In the fiscal year ending March 31, 2025, Ricoh reported consolidated revenue of ¥2.53 trillion (about $16.8 billion USD). Ricoh’s strategy centers on integrating print and digital services to improve workplace efficiency and operational performance. It focuses on developing solutions that adapt work processes to technology shifts and sustainability needs.
About Ricoh 3D for Healthcare

Ricoh 3D for Healthcare, LLC, established in June 2025, operates as a subsidiary of Ricoh USA, Inc., with headquarters in Exton, PA. The company produces medical devices using both centralized manufacturing and point-of-care production models. Its offerings include clinical-grade anatomical models and surgical planning tools, along with production services designed to scale according to healthcare system upgradations. Ricoh 3D for Healthcare serves hospitals and health systems, also works with medical technology companies to support the development and distribution of customized medical devices. The applications span clinical areas, including craniomaxillofacial, orthopedic, cardiovascular, neurological, gastrointestinal, genitourinary, and breast procedures. The company’s approach focuses on integrating 3D printing into routine clinical workflows to improve surgical planning and patient outcomes.